Nociceptive neurons in the rat caudal trigeminal nucleus respond to blood plasma perfusion of the subarachnoid space: The involvement of complement

Pain

Volumn 81, Issue 3, 1999, Pages 283-288

  Ebersberger, Andrea ^a   Handwerker, Hermann O ^b   Reeh, Peter W ^b  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Complement; Headache; Migraine; Plasma; Platelet; Rat

Indexed keywords

ANIMAL MODEL; ARTICLE; COMPLEMENT SYSTEM; CONTROLLED STUDY; HEADACHE; HEMOPERFUSION; MALE; MIGRAINE; NOCICEPTIVE RECEPTOR; NONHUMAN; PRIORITY JOURNAL; RAT; SUBARACHNOID HEMORRHAGE; TRIGEMINAL NUCLEUS;

ANIMALS; BLOOD PLATELETS; COMPLEMENT SYSTEM PROTEINS; DISEASE MODELS, ANIMAL; MALE; MIGRAINE DISORDERS; NOCICEPTORS; PAIN; PERFUSION; PLASMA; RATS; RATS, WISTAR; SUBARACHNOID SPACE; TRIGEMINAL CAUDAL NUCLEUS;

EID: 0032997891     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(99)00017-2     Document Type: Article

References (47)

1. Abbas, A.K., Lichtman, A.H. and Pober, J.S., Cellular and molecular immunology, The complement system, Saunders Harcourt Brace Jovanovich, Philadelphia, PA, 1991, pp. 259-288.
2. Anthony M., Hintenberger H., Lance J.W. The possible relationship of serotonin to the migraine syndrome. Res. Clin. Stud. Headache. 2:1969;29-59.
3. Balkan S., Mutlu G., Kumdalli A., Yagan S. Immunoglobulin and complement levels in migraine. Mikrobiyoloji Bulteni. 20:1986;242-247.
4. Bottomley J.M., Hannington E., Jones R.J., Chapman D. Platelet lipid composition in human migraine. Headache. 22:1982;256-260.
5. 1). Functional Neurol. 8:1993;403-408.
6. Cotrim M.D., Fontes Ribeiro C.A., Macedo T.R.A. Changes in platelet membrane fluidity of migraine patients. Cephalalgia. 13:1993;99-101.
7. Couch J.R., Hassanein R.S. Platelet aggregability in migraine. Neurology. 27:1977;843-848.
8. Dalsgaard-Nielsen T., Genefke I.K. Serotonin (5-hydroxytryptamine) release and uptake in platelets from healthy persons and migraineous patients in attack-free intervals. Headache. 14:1974;26-32.
9. D'Andrea G., Hasselmark L., Alecci M., Canzani A., Welch K.M.A. Platelet secretion from dense and α-granules in vitro in migraine with or without aura. J. Neurol. Neurosurg. Psychiatry. 57:1994;557-561.
10. D'Andrea G., Hasselmark L., Alecci M., Perini F., Welch K.M.A. Increased platelet serotonin content and hypersecretion from dense and α-granules in vitro in tension-type headache. Cephalalgia. 13:1993;349-359.
11. Deshmukh S.V., Stirling Meyer J. Cyclic changes in platelet dynamics and the pathogenesis and prophylaxis of migraine. Headache. 17:1977;101-108.
12. Ebersberger A., Ringkamp M., Reeh P.W., Handwerker H.O. Recordings from brainstem neurons responding to chemical stimulation of the subarachnoid space. J. Neurophysiol. 77:1997;3122-3133.
13. El-Lati S.G., Dahinden C.A., Church M.K. Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells. J. Invest. Dermatol. 102:1994;803-806.
14. Ferrari M.D., Saxena P.R. On serotonin and migraine: a clinical and pharmacological review. Cephalalgia. 13:1993;151-165.
15. Forster C., Handwerker H.O. Automatic classification and analysis of microneurographic spike data using a PC/AT. J. Neurosci. Methods. 31:1990;109-118.
16. Gasque P., Chan P., Fontaine M., Ischenko A., Lamacz M., Götze O., Morgan B.P. Identification and characterization of the complement C5a anaphylatoxin receptor on human astrocytes. J. Immunol. 155:1995;4882-4889.
17. Gawel M., Burkitt M., Clifford Rose F. The platelet release reaction during migraine attacks. Headache. 19:1979;323-327.
18. Goadsby, P.J., The anatomy and physiology of the cerebral circulation in relationship to the assessment and management of headache. In: Refresher Course Syllabus, IASP Refresher Courses on Pain Management, IASP Publications, Seattle, 1993, pp. 115-123.
19. Hilton B.P., Cumings J.N. 5-Hydroxytryptamine levels and platelet aggregation responses in subjects with acute migraine headache. J. Neurol. Neurosurg. Psychiatry. 35:1972;505-509.
20. Hugli, T.E., Structure and function of the anaphylatoxins. In: H.J. Müller-Eberhard, P.A. Miescher (Eds.), Complement, Springer, Berlin, 1984, pp. 73-100.
21. des Arg increases vascular permeability. J. Immunol. 127:1981;2376.
22. Kessler W., Kirchhoff C., Reeh P.W., Handwerker H.O. Excitation of cutaneous afferent nerve endings in vitro by a combination of inflammatory mediators and conditioning effect of substance P. Exp. Brain. Res. 91:1992;467-476.
23. Kuby, J., Immunology. In: The Complement System, W.H. Freeman, New York, 1992, pp. 335-356.
24. Kunkel, S.L., Fantone, J.C. and Ward, P.A., Complement mediated inflammatory reactions, in: H.L. Ioachim (Ed.), Pathobiology Annual 1981, Vol. 11, Raven Press, New York, 1981, pp. 127-154.
25. Launay, J.M., Soliman, H., Brulfert, A., Farjaudon, N., Germani, E., Dreux, C. and Pradalier, A., Number and function of platelet dense bodies in common migraine: a reassessment. In: J. Olesen and P.R. Saxena (Eds.), 5-Hydroxytryptamine Mechanisms in Primary Headaches, Raven Press, New York, 1992, pp. 99-102.
26. Levine S.R., Deegan M.J., Futrell N., Welch K.M.A. Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases. Neurology. 40:1990;1181-1189.
27. Malmgren R., Hasselmark L. The platelet and the neuron: Two cells in focus in migraine. Cephalalgia. 8:1988;7-24.
28. Markus H.S., Hopkinson N. Migraine and headache in systemic lupus erythematosus and their relationship with antibodies against phospholipids. J. Neurol. 239:1992;39-42.
29. Martin-Malo A., Castillo D., Castro M., Perez R., Rios A., Jaraba M., Aljama P. Biocompatibility of dialysis membranes: a comparative study. Nephrol. Dial. Transplant. 6:1991;55-58.
30. Meuner S., Hugli T.E., Andreatta R.H., Hadding U., Bitter-Suermann D. Comparative study on biological activities of various anaphylatoxins (C4a, C3a, C5a), Investigations on their ability to induce platelet secretion. Inflammation. 5:1981;263-273.
31. Montalban J., Cervera R., Font J., Ordi J., Vianna J., Haga H.J., Tintoré M., Khamashta M.A., Hughes G.R.V. Lack of association between anticardiolipin antibodies and migraine in systemic lupus erythematosus. Neurology. 42:1992;681-682.
32. Moskowitz M.A., Macfarlane R. Neurovascular and molecular mechanisms in migraine headaches. Cerebrovasc. Brain Metab. Rev. 5:1993;159-177.
33. Mousli M., Hugli T.E., Landry Y., Bronner C. Peptidergic pathway in human skin and rat peritoneal mast cell activation. Immunopharmacol. 27:1994;1-11.
34. Nozaki K., Boccalini P., Moskowitz M.A. Expression of c-fos-like immunoreactivity in brainstem after meningeal irritation by blood in the subarachnoid space. Neuroscience. 49:1992;669-680.
35. Penfield W., McNaughton F. Dural headache and innervation of the dura mater. Arch. Neurol. Psychiat. 44:1940;43-75.
36. Pradalier A., Launay J.M., Cauet N., Dreux C., Dry J. Plasma releasing factors in common migraine (Facteurs plasmatiques de liberation au cours de la migraine). Presse Med. Paris. 19:1990;501-505.
37. Ray B.S., Wolff H.G. Experimental studies on headache: Pain sensitive structures of the head and their significance in headache. Arch. Surg. 41:1940;813-856.
38. Ringkamp, M., Schmelz, M., Kress, M., Allwang, M., Ogilvie, A. and Reeh, P.W., Activated human platelets in plasma excite nociceptors in rat skin, in vitro, Neurosci. Lett., 170 (1994a) 103-106.
39. Ringkamp, M., Schmelz, M., Allwang, M., Ogilvie, A. and Reeh, P.W., Nociceptor excitation by platelets is not due to 5-HT or prostanoids released, Soc. Neurosci. Abstr., 20 (1994b) 1569.
40. Sangiorgi S., Mochi M., Riva R., Cortelli P., Monari L., Pierangeli G., Montagna P. Abnormal platelet mitochondrial function in patients affected by migraine with and without aura. Cephalalgia. 14:1994;21-23.
41. Schmelz M., Osiander G., Blunk J., Ringkamp M., Reeh P.W., Handwerker H.O. Intradermal injections of human platelets cause acute pain and protracted hyperalgesia. Neurosci. Lett. 226:1997;171-174.
42. Schmelz, M., Blunk, J., Osiander, G. and Nischik, M., Pain and inflammatory hyperalgesia induced by intradermal injections of human platelets and leukocytes, Eur. J. Pain, (1998) submitted.
43. Scrutton, M.C. and Bawa, S., 5-HT, platelets, and migraine: Is there a relationship? In: J. Olesen and P.R. Saxena (Eds.), 5-Hydroyxtryptamine Mechanisms in Primary Headaches, Raven Press, New York, 1992, pp. 61-68.
44. Steen, K.H., Steen A.E. and Reeh, P.W., A dominant role of acid pH in inflammatory excitation and sensitization of nociceptors in rat skin, in vitro, J. Neurosci., 15 (1995) 3982-3989.
45. Steiner T.J., Joseph R., Clifford Rose F. Migraine is not a platelet disorder. Headache. 25:1985;434-440.
46. Stimler N.P., Bloor C.M., Hugli T.E. C3a-induced contraction of guinea pig lung parenchymal: role of cyclooxygenase metabolites. Immunopharmacol. 5:1983;251.
47. Yancey K.B., Swerlick R.A., Lawely T.J. C5a as a mediator of cutaneous inflammation. Am. J. Dermatopathol. 9:1987;138-143.